E
USNA icon

Ergoteles’s Usana Health Sciences USNA Stock Holding History

Ergoteles’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,497
Closed -$252K – 1913
2022
Q3 		$252K Sell
4,497
-1,400
-24% -$92.5K 0.01% 1067
2022
Q2 		$427K Buy
+5,897
New +$439K 0.01% 909
2022
Q1 		– Sell
-4,400
Closed -$445K – 1647
2021
Q4 		$445K Buy
4,400
+2,200
+100% +$219K 0.02% 690
2021
Q3 		$203K Buy
+2,200
New +$212K 0.01% 992

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's USNA Position: Q4 2022 in Review

Ergoteles sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 4,497 shares — an estimated $252K sold.

Ergoteles first reported a position in USNA in Q3 2021 and held it in 4 quarters. The position peaked at $445K in Q4 2021. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

  • Ergoteles reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 4,497 Usana Health Sciences shares in Q4 2022, an estimated $252K.
  • Ergoteles first reported a position in Usana Health Sciences in Q3 2021 and held it in 4 quarters.
  • Ergoteles's Usana Health Sciences position peaked at $445K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.